CuraTeQ Biologics Ends Licensing Agreement With BioFactura for Ustekinumab Biosimilar
CuraTeQ Biologics Private Limited, the biologics-focused subsidiary of Aurobindo Pharma Limited, has decided to mutually terminate its licensing agreement with […]
CURATEQ-BIOLOGICS
Aurobindo Pharma Arm Extends Negotiations Deadline with MSD for Contract Manufacturing Operations
Aurobindo Pharma, a leading pharmaceutical company, has announced the extension of negotiations between its subsidiary, CuraTeQ Biologics, and Merck Sharp […]
